Plain-English translation of NCT05828823 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a personalized dialysis approach works better than the standard approach for people newly starting dialysis. Instead of the typical three dialysis sessions per week, some patients will receive a customized schedule that starts with twice-weekly sessions and is adjusted based on how much kidney function they still have and their individual symptoms. The study will look at whether this personalized approach improves quality of life, reduces fatigue, helps people stay employed, and eases the burden on family caregivers.
When people start dialysis, they often still have some remaining kidney function that can help filter waste from their blood. The standard dialysis schedule doesn't account for this remaining function, which may mean some patients are over-treated while others may not get enough treatment. This trial is designed to see whether tailoring the dialysis schedule to match each person's actual kidney function could lead to better health outcomes and a better quality of life.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either the personalized dialysis group or the standard three-times-weekly dialysis group. The personalized group will start with two dialysis sessions per week, with the schedule adjusted based on your remaining kidney function and how you feel. You will have regular check-ins with the study team to monitor your health, and you'll answer questions about your quality of life, fatigue, and ability to work. The study will also track hospitalizations and how well your kidneys continue to function.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States